Skip to main content

Biopharma Startups

Updated October 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 906 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
906
Total Funding
$893.0M
Avg Funding
$35.7M
Global Reach
9
countries

Top Cities for Biopharma

Indianapolis
Fremont
Cambridge
Franklin
Napoli
Cardiff

Recently Funded Companies

Export
Indianapolis, United States

Formulary Insights help biopharmaceutical investors, marketers, and leaders understand and anticipate payer perceptions of their product.

$1.7M raised
Jul 2021

Founder Contacts

41,000+ verified contacts

Fremont, United States

ABVC Biopharma is a clinical-stage biopharmaceutical company that identifies drugs and medical devices under development.

$1.8M raised
Jul 2023

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing.

$3.3M raised
Jul 2024

Founder Contacts

41,000+ verified contacts

Franklin, United States

Adora Life Science is a Biotechnology firm developing and researching on pharmaceutical related to inflammation, diabetes and regeneration.

$1.0M raised
Jul 2025

Founder Contacts

41,000+ verified contacts

Napoli, Italy

FTnet connects the Pharmaceutical Industry and Pharmacy through multi-sided technology.

$4.7M raised
Jul 2025

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom

Sano Genetics is a molecular diagnostics company that specializes in developing and commercializing genetic tests for inherited diseases.

Jul 2024

Founder Contacts

41,000+ verified contacts

Cardiff, United Kingdom

Patient-centric cancer data and analytics platform for translational cancer biologists

Jul 2024

Founder Contacts

41,000+ verified contacts

Singapore, Singapore

Tikva Allocell is a biotechnology company that specializes in next-gen cell therapies.

$8.0M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

Crystalys Therapeutics is a clinical-stage biopharmaceutical company that develops targeted therapies for gout and hyperuricemia.

$130.0M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Geneva, Switzerland

Azure Cell Therapies is a biotech company developing next-gen CGTs for neurodegenerative diseases

$189K raised
Jul 2025

Founder Contacts

41,000+ verified contacts

Conshohocken, United States

Madrigal Pharmaceuticals is a biopharmaceutical company developing therapeutics for the treatment of cardiovascular-metabolic diseases.

$350.0M raised
Jul 2025

Founder Contacts

41,000+ verified contacts

Tokyo, Japan

RIN Institute is a bio-venture firm dedicated to the research and development of antibody-based medicines and external diagnostic drugs.

Jul 2021

Founder Contacts

41,000+ verified contacts

Venice, United States

Seed develops clinically-studied probiotics to impact human and planetary health.

$925K raised
Jul 2022

Founder Contacts

41,000+ verified contacts

Rosario, Argentina

Exomas develops exosome-based products that expand the cognitive reserve and induce neuronal plasticity to treat neurodegenerative diseases.

$31K raised
Jul 2025

Founder Contacts

41,000+ verified contacts

Warsaw, Poland

Molecure is an innovative biopharmaceutical company that specializes in discovery, development, and commercialization of novel therapeutics.

$12.6M raised
Jul 2023

Founder Contacts

41,000+ verified contacts

Toronto, Canada

Pike Therapeutics specializes in developing safe and effective cannabinoid formulations with superior drug delivery.

$760K raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Tokyo, Japan

Renalys Pharma is a clinical-stage biopharmaceutical company developing therapeutics for renal disease in Asian patients.

$38.5M raised
Jul 2024

Founder Contacts

41,000+ verified contacts

New York, United States

Cambrian is a distributed development company building therapeutics to lengthen health span.

$123.8M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Cardiff, United Kingdom

Draig Therapeutics is a clinical-stage biopharmaceutical company that develops investigational therapies for neuropsychiatric disorders.

$65.0M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Felix Biotechnology is working to accelerate the deployment of novel biotherapeutics to manage infectious diseases.

$314K raised
Jul 2022

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.

$50.0M raised
Jul 2021

Founder Contacts

41,000+ verified contacts

Los Altos, United States

Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.

$100.0M raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Morristown, United States

B1 Health offers a platform for clinical trial design optimization, documentation, process tracking & insight generation for biotech firms.

$350K raised
Jul 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom

Healx is a rare disease biotechnology company that uses generative AI for drug discovery.

Jul 2025

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Enabling immune infiltration of the tumor microenvironment

Jul 2023

Founder Contacts

41,000+ verified contacts

Showing 151 to 175 of 906 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 906 biopharma companies tracked in the VCBacked database.

Average Funding
$35.7M
Total Funding Tracked
$893.0M
Countries Represented
9

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Cambridge
4 companies$53.3M
2.Cardiff
2 companies$65.0M
3.Tokyo
2 companies$38.5M
4.San Francisco
2 companies$314K
5.Indianapolis
1 companies$1.7M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

906 Biopharma Startups (2026) — Recently Funded — Page 7 | VCBacked